Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to predict CAR-T success in lymphoma patients

NCT ID NCT06352242

Recruiting now Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 25, 2026 · Updated 28 times

Summary

This study looks at whether a natural cell process called trogocytosis can help predict if CAR-T cell therapy will work for people with a type of blood cancer called diffuse large B-cell lymphoma. Researchers will measure trogocytosis levels in blood samples from 85 patients before and after treatment. The goal is to find a pattern that shows who is likely to respond well to CAR-T therapy and who might need a different approach.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinical Investigation Center, University Hospital

    RECRUITING

    Montpellier, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Clinical hematology department, University Hospital

    RECRUITING

    Montpellier, France

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

DIFFUSE LARGE B-CELL LYMPHOMA